2013 was a multimillion-dollar year for leading Israeli agritech and medtech startups
This post was written by Karen Kozek from The Trendlines Group, Israel’s leading agritech and medtech incubator. It’s that time again. A time to take a look back at Trendlines and our portfolio companies in 2013. Last year, our portfolio companies raised ~$20 million (~NIS 70 million). Among these companies were LapSpace, Leviticus Cardio and MitrAssist. As well, ApiFix completed its second funding round. Last year marked the first time our companies received investments from Chinese investors. Since 2007, our portfolio companies have raised $140 million (not including government funding). With our entrepreneur partners, we created 9 new companies in 2013. On the agritech side, BioFishency, FuturaGraft, Metabolic Robots, Saturas, and Valentis started up. And in medical, we established Arch2Fix, Omeq Medical, STS Medical, and VisiDome. Since 2007, Trendlines has started 52 medical and agricultural technology companies. Our portfolio now numbers 55, including 15 revenue-stage companies. We announced 2 exits last year, and both involved major global players: Teleflex acquired Innolap and Baxter acquired FlowSense. Awards & Recognition A number of our companies gained local and international recognition last year. Israel’s Office of the Chief Scientist named ApiFix and Sol Chip “Best Start-Ups.” Sol Chip also received the award for Best Technical Development of Energy Harvesting at IDTechEx 2013 IDTechEx. GreenSpense walked away two awards from the 2013 International Cleantech Open...
Read More